Published 1 day ago • loading... • Updated 1 day ago
Tech for Good: Alibaba Brings Frontier AI Out of the Lab to Revolutionize Early Cancer Screening Globally
Alibaba Group is bridging the gap between artificial intelligence research and clinical practice to improve global public health.
Alibaba has launched DAMOMED, a medical AI early screening platform that uses routine CT scans and deep-learning algorithms for accessible early cancer detection worldwide.
The PANDA model, developed by Alibaba, enables multiple screenings for early pancreatic cancer detection from a single scan.
Research on the PANDA model was published in Nature Medicine and recognized as a milestone by Stanford University's AI Index Report.